Trulieve Reports Results of 2020 Annual General Meeting
TALLAHASSEE, FL, June 4, 2020 /CNW/ - Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company based in the United States, today announced the results of its Annual General Meeting of Shareholders held on June 2, 2020 (the "Meeting"). Each of the eight individuals nominated for election as a director of Trulieve at the Meeting were elected, including new nominees, Susan Thronson and Thomas Millner.
Ms. Thronson is an experienced independent director with global digital, ecommerce and loyalty marketing experience. Ms. Thronson was Senior Vice President of Global Marketing for Marriott International from 1989 to 2013, leading Marriott's worldwide integrated marketing strategy and execution for its 15 hotel brands. Ms. Thronson formerly served as a director of Angie's List from 2012 to 2017, an internet service company, and SONIC Drive-In from 2015 to 2018, an operator of an American drive-in fast-food restaurant chain based in Oklahoma City, Oklahoma.
Mr. Millner brings a combination of executive leadership, merchandising and multichannel operational skills, and a strong philanthropic background to the Company. Mr. Milner served as CEO of Cabela's, a direct marketer and specialty retailer of outdoor recreation merchandise, from 2009 to 2017. Prior to Cabela's, Mr. Milner was president and CEO of North Carolina's Remington Arms Company from 1994 to 2009, an American manufacturer of firearms and ammunition. Mr. Millner has been serving as a director and the chair of the audit committee of Best Buy since 2014, a multinational consumer electronics retailer and is a former director of Total Wine & More, a large, family-owned, privately held American alcohol retailer from 2015 to 2019.
"Ms. Thronson and Mr. Millner both bring extensive retail and hospitality backgrounds to Trulieve and their strong consumer focus makes them outstanding additions to our Board," said Trulieve CEO Kim Rivers. "Their combined global retail experience is a significant asset to our team as we continue to execute on our strategic growth plans for the year and navigate through the new environment brought about by COVID-19."
The Company put forward the following resolutions to be voted on by shareholders at the meeting, all of which were approved: (i) to elect the Directors of the Corporation for the ensuing year; and (ii) to appoint MNP LLP as the Auditors of the Corporation for the 2020 fiscal year and authorizing the Directors to fix their remuneration.
A total of 149,968,657 of the 178,159,646 of the votes attached to all outstanding shares of the Company on an as-converted basis as at the record date voted at the meeting, representing 84.2% of outstanding shares on an as-converted basis.
Election of Directors:
Each of the directors elected at the Meeting, being Kim Rivers, Thad Beshears, George Hackney, Richard May, Michael O'Donnell, Peter Healy, Susan Thronson, and Thomas Millner will hold office until the next annual general meeting of the Company or until their earlier resignation or removal. Detailed results of the vote for the election of directors are set out below.
Appointment of Auditors:
MNP LLP were appointed as Auditors of the Corporation for the 2020 fiscal year with the Directors authorized to fix their remuneration. Detailed results are below.
Appointment of Auditors
Trulieve is a vertically integrated "seed-to-sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts, and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.
To learn more about Trulieve, visit www.Trulieve.com.
SOURCE Trulieve Cannabis Corp.
Upcoming Life Sciences Events
- July 2020
- Digital Novel Coronavirus Investment Forum Empowering Early
- Florida: Evolution Summit
- Taipei: BIO Asia-Taiwan